KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to 0.51.

  • Pacira BioSciences' Asset Utilization Ratio rose 1528.2% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 1528.2%. This contributed to the annual value of 0.45 for FY2024, which is 808.95% up from last year.
  • Per Pacira BioSciences' latest filing, its Asset Utilization Ratio stood at 0.51 for Q3 2025, which was up 1528.2% from 0.45 recorded in Q2 2025.
  • Pacira BioSciences' Asset Utilization Ratio's 5-year high stood at 0.51 during Q3 2025, with a 5-year trough of 0.29 in Q1 2022.
  • For the 5-year period, Pacira BioSciences' Asset Utilization Ratio averaged around 0.41, with its median value being 0.43 (2024).
  • As far as peak fluctuations go, Pacira BioSciences' Asset Utilization Ratio tumbled by 3437.86% in 2021, and later skyrocketed by 4269.4% in 2023.
  • Quarter analysis of 5 years shows Pacira BioSciences' Asset Utilization Ratio stood at 0.32 in 2021, then grew by 23.71% to 0.39 in 2022, then rose by 11.21% to 0.43 in 2023, then rose by 4.99% to 0.46 in 2024, then rose by 10.93% to 0.51 in 2025.
  • Its Asset Utilization Ratio stands at 0.51 for Q3 2025, versus 0.45 for Q2 2025 and 0.45 for Q1 2025.